Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 17, 2023 01:00 ET | Source: Xeltis

Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023

Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023 aXess demonstrated exceptional patency rates and no infections to date...
August 14, 2023 02:00 ET | Source: Xeltis

Xeltis secures additional €12.5 million from European Innovation Council Fund in final close of D2 financing

Xeltis secures additional €12.5 million from European Innovation Council Fund in final close of D2 financing Funding extends Xeltis’ Series D2 financing round to €44.5 million EINDHOVEN, The...
April 28, 2023 02:00 ET | Source: Xeltis

Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress

Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress aXess graft demonstrated excellent patency, low rates of...
February 21, 2023 01:00 ET | Source: Xeltis

Xeltis raises €32 million to drive clinical development of world’s most advanced restorative cardiovascular devices

Xeltis raises €32 million to drive clinical development of world’s most advanced restorative cardiovascular devices New investors DaVita Venture Group and Invest-NL join syndicate of international...